Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19028890 | DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISM | January 2025 | March 2025 | Allow | 2 | 0 | 0 | No | No |
| 19000461 | Smart IV Pole: An Integrated Solution for Medical Device Connectivity, Patient Monitoring, and Communication | December 2024 | May 2025 | Allow | 4 | 1 | 0 | Yes | No |
| 18968283 | DOSING OF INCRETIN PATHWAY DRUGS | December 2024 | May 2025 | Allow | 5 | 1 | 0 | No | No |
| 18960470 | Medicament Container Carrier and Adapter | November 2024 | June 2025 | Allow | 6 | 0 | 1 | No | No |
| 18960071 | Medicament Container Carrier and Adapter | November 2024 | February 2025 | Allow | 3 | 0 | 0 | No | No |
| 18957952 | Medicament Container Carrier and Adapter | November 2024 | June 2025 | Allow | 6 | 0 | 1 | No | No |
| 18806797 | INTEGRATED INSULIN DELIVERY SYSTEM WITH CONTINUOUS GLUCOSE SENSOR | August 2024 | April 2025 | Allow | 8 | 1 | 1 | Yes | No |
| 18785610 | INTEGRATED INSULIN DELIVERY SYSTEM WITH CONTINUOUS GLUCOSE SENSOR | July 2024 | September 2024 | Allow | 2 | 0 | 0 | No | No |
| 18735124 | METHOD AND SYSTEM FOR TUNING HORMONE RECEPTORS THROUGH THE DYNAMIC INTRAVENOUS DELIVERY OF A HORMONE ACCORDING TO A TARGET PHYSIOLOGICAL CADENCE | June 2024 | October 2024 | Allow | 5 | 1 | 0 | Yes | No |
| 18599791 | Medicament Container Carrier and Adapter | March 2024 | May 2024 | Allow | 3 | 0 | 0 | No | No |
| 18428921 | BLOOD GLUCOSE SENSING SYSTEM | January 2024 | August 2024 | Allow | 7 | 1 | 0 | Yes | No |
| 18426297 | LIQUID MEDICINE INJECTION DEVICE | January 2024 | May 2024 | Allow | 3 | 0 | 0 | No | No |
| 18407094 | COMBINED NEEDLE AND CANNULA | January 2024 | October 2024 | Abandon | 9 | 1 | 0 | No | No |
| 18390338 | AUTOMATICALLY OR MANUALLY INITIATED MEAL BOLUS DELIVERY WITH SUBSEQUENT AUTOMATIC SAFETY CONSTRAINT RELAXATION | December 2023 | May 2024 | Allow | 5 | 1 | 0 | No | No |
| 18538438 | IMPLANTABLE CELLULAR AND BIOTHERAPEUTIC AGENT DELIVERY CANISTER | December 2023 | December 2024 | Allow | 12 | 2 | 0 | No | No |
| 18482596 | INSULIN MANAGEMENT | October 2023 | February 2024 | Allow | 4 | 1 | 0 | Yes | No |
| 18373558 | SYSTEMS AND METHODS FOR COACHING INHALER USE VIA SYNCHRONIZING PATIENT AND RESPIRATORY CYCLE BEHAVIORS | September 2023 | December 2023 | Allow | 3 | 0 | 0 | No | No |
| 18235091 | BIOINTEGRATIVE IMPLANTABLE CELL ENCAPSULATION DEVICE AND SYSTEM | August 2023 | May 2024 | Allow | 9 | 0 | 0 | No | No |
| 18325564 | METHOD, SYSTEM AND COMPUTER PROGRAM PRODUCT FOR CGM-BASED PREVENTION OF HYPOGLYCEMIA VIA HYPOGLYCEMIA RISK ASSESSMENT AND SMOOTH REDUCTION INSULIN DELIVERY | May 2023 | January 2024 | Allow | 8 | 2 | 0 | No | No |
| 18316703 | TECHNIQUES TO REDUCE RISK OF OCCLUSIONS IN DRUG DELIVERY SYSTEMS | May 2023 | March 2025 | Allow | 22 | 0 | 0 | No | No |
| 18314791 | REAL-TIME MEAL DETECTION BASED ON SENSOR GLUCOSE AND ESTIMATED PLASMA INSULIN LEVELS | May 2023 | July 2023 | Allow | 2 | 0 | 0 | No | No |
| 18310731 | APPARATUS AND METHOD FOR SENSOR DEPLOYMENT AND FIXATION | May 2023 | June 2025 | Allow | 25 | 1 | 0 | No | No |
| 18033137 | METHOD FOR CONTROLLING ARTIFICIAL PANCREAS INCLUDING INSULIN PATCH AND DEVICE THEREFOR | April 2023 | November 2023 | Allow | 7 | 0 | 0 | No | No |
| 18304117 | INFUSION PUMP SYSTEM AND METHODS | April 2023 | October 2023 | Allow | 6 | 1 | 0 | No | No |
| 18295015 | Insulin Management | April 2023 | June 2023 | Allow | 3 | 0 | 0 | No | No |
| 18190678 | ACTIVITY MODE FOR ARTIFICIAL PANCREAS SYSTEM | March 2023 | June 2025 | Allow | 27 | 1 | 0 | No | No |
| 18122012 | Acoustic Method for Precisely Controlling and Metering the Manual Injection Dosage | March 2023 | November 2023 | Allow | 8 | 1 | 0 | No | No |
| 18119650 | IV FLOW MANAGEMENT SYSTEMS AND METHODS | March 2023 | May 2025 | Allow | 27 | 1 | 0 | No | No |
| 18116962 | LIQUID MEDICINE INJECTION DEVICE | March 2023 | October 2023 | Allow | 8 | 0 | 0 | No | No |
| 18176532 | SYSTEMS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS | March 2023 | May 2024 | Allow | 14 | 1 | 0 | No | No |
| 18114961 | ASSEMBLIES, SYSTEMS AND METHODS FOR PROGRAMMING MEDICAL DEVICES | February 2023 | May 2024 | Allow | 15 | 1 | 0 | Yes | No |
| 18108195 | MULTIPLE USE DISPOSABLE INJECTION PEN | February 2023 | February 2025 | Allow | 24 | 0 | 0 | No | No |
| 18161226 | INTEGRATED VASCULAR DELIVERY SYSTEM | January 2023 | April 2025 | Allow | 26 | 1 | 0 | No | No |
| 18067417 | PREDICTION BASED DELIVERING OR GUIDING OF THERAPY FOR DIABETES | December 2022 | March 2025 | Allow | 27 | 1 | 0 | No | No |
| 18066517 | METHOD FOR FABRICATING WEARABLE HYDROGEL GLUCOSE SENSOR | December 2022 | July 2023 | Allow | 7 | 0 | 0 | No | No |
| 18066790 | INJECTION MONITORING DEVICE | December 2022 | March 2025 | Allow | 27 | 1 | 0 | No | No |
| 18078346 | DEVICE AND METHOD FOR DELIVERING A MEDICAMENT | December 2022 | January 2025 | Allow | 26 | 0 | 0 | No | No |
| 18072207 | LOW CONCENTRATION DELIVERY OF AN ERGOLINE DERIVATIVE FOR TREATMENT OF A HEADACHE | November 2022 | May 2025 | Allow | 29 | 1 | 0 | No | No |
| 18058041 | SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATION | November 2022 | February 2023 | Allow | 3 | 0 | 0 | No | No |
| 17984100 | PRE-CONNECTED ANALYTE SENSORS | November 2022 | April 2025 | Abandon | 29 | 1 | 0 | No | No |
| 17972117 | IMPLANTABLE CELLULAR AND BIOTHERAPEUTIC AGENT DELIVERY CANISTER | October 2022 | August 2023 | Allow | 10 | 1 | 1 | No | No |
| 17935483 | TECHNIQUES ENABLING ADAPTATION OF PARAMETERS IN AID SYSTEMS BY USER INPUT | September 2022 | April 2023 | Allow | 6 | 1 | 0 | Yes | No |
| 17933249 | SYSTEM AND METHOD FOR ADJUSTING INSULIN DELIVERY | September 2022 | February 2025 | Allow | 29 | 1 | 0 | Yes | No |
| 17821150 | DYNAMIC FORECASTS | August 2022 | December 2024 | Allow | 28 | 0 | 0 | No | No |
| 17818504 | USER PARAMETER DEPENDENT COST FUNCTION FOR PERSONALIZED REDUCTION OF HYPOGLYCEMIA AND/OR HYPERGLYCEMIA IN A CLOSED LOOP ARTIFICIAL PANCREAS SYSTEM | August 2022 | June 2025 | Allow | 34 | 1 | 0 | No | No |
| 17884508 | EXOSKELETON DEVICE WITH EXPANDABLE SECTION FOR SCORING | August 2022 | March 2025 | Allow | 31 | 1 | 0 | Yes | No |
| 17818136 | Systems and Methods for Monitoring and Controlling Fluid Infusion to a Patient | August 2022 | October 2024 | Allow | 26 | 0 | 0 | No | No |
| 17878217 | INFUSION DEVICE SYSTEM AND APPARATUS | August 2022 | May 2025 | Allow | 33 | 1 | 1 | No | No |
| 17876862 | MEDICAMENT DELIVERY DEVICE | July 2022 | December 2024 | Allow | 28 | 0 | 0 | No | No |
| 17759512 | METHOD AND APPARATUS FOR DISPLAYING PROGRESS INFORMATION | July 2022 | June 2025 | Allow | 35 | 0 | 0 | No | No |
| 17851068 | Method and System of Remote Control and Remote Monitor in Treating Respiratory Patients | June 2022 | October 2022 | Allow | 4 | 1 | 0 | No | No |
| 17843631 | Feedback Mechanism for an Injection Device | June 2022 | March 2025 | Abandon | 33 | 1 | 0 | No | No |
| 17842564 | Fluid Delivery and Measurement Systems and Methods | June 2022 | May 2025 | Abandon | 35 | 1 | 0 | No | No |
| 17841042 | LOW CONCENTRATION DELIVERY OF AN ERGOLINE DERIVATIVE FOR TREATMENT OF A HEADACHE | June 2022 | October 2022 | Allow | 4 | 1 | 0 | No | No |
| 17831189 | RADIAL AND TRANS-ENDOCARDIAL DELIVERY CATHETER | June 2022 | April 2025 | Allow | 34 | 1 | 0 | No | No |
| 17752236 | OPTIMIZING EMBEDDED FORMULATIONS FOR DRUG DELIVERY | May 2022 | May 2025 | Allow | 36 | 1 | 0 | No | No |
| 17756232 | LIQUID DELIVERY DEVICE AND METHOD | May 2022 | April 2025 | Allow | 35 | 0 | 0 | No | No |
| 17744607 | CONTEXT-SENSITIVE INFUSION DEVICES, SYSTEMS AND METHODS | May 2022 | December 2024 | Allow | 31 | 1 | 0 | No | No |
| 17737107 | Data Collection Device for Attachment to an Injection Device | May 2022 | October 2024 | Allow | 29 | 0 | 0 | No | No |
| 17736813 | Methods and Devices for Burden-free Blood Glucose Management With Minimal User Interaction | May 2022 | January 2025 | Allow | 32 | 1 | 0 | No | No |
| 17736825 | Methods and Devices for Minimally Burdensome Blood Glucose Management for Insulin-requiring Diabetes | May 2022 | November 2024 | Allow | 31 | 1 | 0 | No | No |
| 17732771 | METHOD AND DEVICE FOR HAIR LOSS PREDICTION AND PERSONALIZED SCALP CARE | April 2022 | August 2022 | Allow | 4 | 0 | 0 | No | No |
| 17728221 | OPIOID MANAGEMENT SYSTEM | April 2022 | November 2024 | Allow | 30 | 1 | 0 | No | No |
| 17771069 | SYSTEM FOR INTERROGATING SERIALLY-CONNECTED DRUG MODULES IN A COMBINATORIAL DRUG DELIVERY DEVICE | April 2022 | May 2025 | Allow | 36 | 0 | 0 | No | No |
| 17725202 | DEVICE AND METHOD FOR DELIVERING A MEDICAMENT | April 2022 | September 2024 | Allow | 29 | 0 | 0 | No | No |
| 17719224 | PRE-CONNECTED ANALYTE SENSORS | April 2022 | December 2022 | Abandon | 9 | 1 | 0 | No | No |
| 17719181 | PRE-CONNECTED ANALYTE SENSORS | April 2022 | September 2022 | Allow | 5 | 1 | 0 | No | No |
| 17718156 | BREAST PUMP MILK FLOW RATE SENSOR SYSTEM AND APPARATUS | April 2022 | October 2024 | Allow | 31 | 1 | 0 | No | No |
| 17715589 | COMPENSATION FOR MISSING READINGS FROM A GLUCOSE MONITOR IN AN AUTOMATED INSULIN DELIVERY SYSTEM | April 2022 | October 2024 | Allow | 30 | 1 | 0 | No | No |
| 17713800 | Systems and Methods for Regulating Fluid Infusion in a Patient | April 2022 | July 2024 | Allow | 27 | 0 | 0 | No | No |
| 17657086 | CLOUD-CONNECTED AMBULATORY PUMP INTEGRATION | March 2022 | August 2022 | Allow | 4 | 0 | 0 | No | No |
| 17690755 | Personal medical device for administering treatment via mucous membrane | March 2022 | November 2023 | Allow | 20 | 2 | 1 | No | No |
| 17687808 | ADAPTIVE UPDATE OF AUTOMATIC INSULIN DELIVERY (AID) CONTROL PARAMETERS | March 2022 | April 2025 | Allow | 37 | 1 | 0 | No | No |
| 17687201 | BASAL TITRATION WITH ADAPTIVE TARGET GLUCOSE LEVEL | March 2022 | July 2024 | Allow | 28 | 0 | 0 | No | No |
| 17653170 | MEDICAMENT PUMPS AND CONTROL SYSTEMS FOR MANAGING GLUCOSE CONTROL THERAPY DATA OF A SUBJECT | March 2022 | August 2022 | Allow | 5 | 0 | 0 | No | No |
| 17685235 | AMBULATORY MEDICAMENT DEVICE WITH MOTION DETECTION AND GESTURE-BASED CONTROL | March 2022 | March 2023 | Allow | 12 | 1 | 0 | No | No |
| 17653088 | INFUSION PUMP WITH SAFETY SEQUENCE KEYPAD | March 2022 | January 2025 | Allow | 34 | 1 | 0 | No | No |
| 17652448 | SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATION | February 2022 | September 2022 | Allow | 7 | 1 | 0 | No | No |
| 17670967 | SYSTEM AND METHOD FOR IMPROVING THE DRUG THERAPY MANAGEMENT | February 2022 | August 2024 | Allow | 30 | 1 | 0 | No | No |
| 17671227 | INFUSION PUMP SYSTEM AND METHOD WITH COMMON LINE AUTO FLUSH | February 2022 | June 2024 | Allow | 28 | 0 | 0 | No | No |
| 17668687 | CUSHION FOR MASK SYSTEM | February 2022 | December 2024 | Abandon | 35 | 1 | 0 | No | No |
| 17584748 | IMPLANTABLE CELLULAR AND BIOTHERAPEUTIC AGENT DELIVERY CANISTER | January 2022 | August 2023 | Allow | 19 | 1 | 1 | No | No |
| 17575306 | SYSTEM AND METHOD FOR SWITCHING BETWEEN MEDICAMENT DELIVERY CONTROL ALGORITHMS | January 2022 | July 2024 | Allow | 31 | 0 | 0 | No | No |
| 17569528 | Facilitating Remote Control Of Oxygen Supply | January 2022 | May 2022 | Allow | 4 | 0 | 0 | No | No |
| 17566840 | ANTIARRHYTHMIC DRUG DOSING METHODS, MEDICAL DEVICES, AND SYSTEMS | December 2021 | July 2022 | Allow | 7 | 1 | 0 | No | No |
| 17646598 | CONTEXTUAL ADJUSTMENT OF CONTROL PARAMETERS | December 2021 | September 2024 | Allow | 33 | 1 | 0 | No | No |
| 17645693 | CONTEXTUAL ADJUSTMENT OF INSULIN ABSORPTION CURVES | December 2021 | April 2024 | Allow | 28 | 0 | 0 | No | No |
| 17556574 | OPTIMIZED INTRATHECAL DRUG DELIVERY | December 2021 | July 2024 | Allow | 31 | 1 | 0 | No | No |
| 17554978 | Rapidly Insertable Central Catheters, Assemblies, And Methods Thereof | December 2021 | July 2024 | Allow | 31 | 1 | 0 | Yes | No |
| 17596591 | ULTRASOUND-INDUCED POSITIONING TYPE PUNCTURE ASSEMBLY AND SLEEVE TYPE SMALL NEEDLE KNIFE | December 2021 | May 2025 | Allow | 42 | 1 | 0 | No | No |
| 17549935 | Model-Based Personalization Scheme of an Artificial Pancreas for Type I Diabetes Applications | December 2021 | May 2024 | Allow | 29 | 1 | 0 | No | No |
| 17550458 | Systems and Methods for Monitoring and Controlling Fluid Infusion to a Patient | December 2021 | April 2022 | Allow | 4 | 0 | 0 | No | No |
| 17548023 | DERMAL SPRAY APPARATUS AND METHOD | December 2021 | May 2022 | Allow | 6 | 1 | 0 | Yes | No |
| 17541673 | DETERMINATION OF ADJUSTMENTS TO FLUID DELIVERY SETTINGS | December 2021 | July 2024 | Allow | 31 | 1 | 0 | No | No |
| 17539270 | OPTIMIZING EMBEDDED FORMULATIONS FOR DRUG DELIVERY | December 2021 | February 2022 | Allow | 3 | 0 | 0 | No | No |
| 17534323 | EXOSKELETON DEVICE WITH EXPANDABLE SECTION FOR SCORING | November 2021 | July 2024 | Allow | 32 | 1 | 0 | No | No |
| 17526428 | MEDICAL BALLOON | November 2021 | December 2024 | Allow | 37 | 1 | 1 | Yes | No |
| 17526154 | MULTI-LANGUAGE / MULTI-PROCESSOR INFUSION PUMP ASSEMBLY | November 2021 | June 2024 | Allow | 31 | 1 | 0 | No | No |
| 17517368 | Stabilizing Connector Devices for Vascular Access and Methods of Using the Same | November 2021 | July 2024 | Allow | 32 | 1 | 0 | No | No |
| 17513941 | INFUSION OF DRUGS | October 2021 | March 2024 | Allow | 29 | 0 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner MENDEZ, MANUEL A.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 41.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner MENDEZ, MANUEL A works in Art Unit 3783 and has examined 710 patent applications in our dataset. With an allowance rate of 93.2%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 29 months.
Examiner MENDEZ, MANUEL A's allowance rate of 93.2% places them in the 80% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.
On average, applications examined by MENDEZ, MANUEL A receive 1.05 office actions before reaching final disposition. This places the examiner in the 14% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by MENDEZ, MANUEL A is 29 months. This places the examiner in the 49% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +6.7% benefit to allowance rate for applications examined by MENDEZ, MANUEL A. This interview benefit is in the 35% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 33.3% of applications are subsequently allowed. This success rate is in the 66% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 65.5% of cases where such amendments are filed. This entry rate is in the 87% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 76% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 63.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 20.1% are granted (fully or in part). This grant rate is in the 11% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 3.8% of allowed cases (in the 86% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 25.4% of allowed cases (in the 94% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.